Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Annelie J E, Vulink"'
Autor:
Sonja Vliek, Florentine S. Hilbers, Erik van Werkhoven, Ingrid Mandjes, Rob Kessels, Sieta Kleiterp, Esther H. Lips, Lennart Mulder, Mutamba T. Kayembe, Claudette E. Loo, Nicola S. Russell, Marie-Jeanne T. F. D. Vrancken Peeters, Marjo J. Holtkamp, Margaret Schot, Joke W. Baars, Aafke H. Honkoop, Annelie J. E. Vulink, Alex L. T. Imholz, Suzan Vrijaldenhoven, Franchette W. P. J. van den Berkmortel, Jetske M. Meerum Terwogt, Jolanda G. Schrama, Philomeen Kuijer, Judith R. Kroep, Annemieke van der Padt-Pruijsten, Jelle Wesseling, Gabe S. Sonke, Kenneth G. A. Gilhuijs, Agnes Jager, Petra Nederlof, Sabine C. Linn
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-9 (2023)
Abstract Exploratory analyses of high-dose alkylating chemotherapy trials have suggested that BRCA1 or BRCA2-pathway altered (BRCA-altered) breast cancer might be particularly sensitive to this type of treatment. In this study, patients with BRCA-alt
Externí odkaz:
https://doaj.org/article/8df2c3c9b54e4fdaa94ca1a2ca82efc6
Autor:
Annelieke A. Lemij, Nienke A. de Glas, Marloes G. M. Derks, Esther Bastiaannet, Jos W. S. Merkus, Titia E. Lans, Carmen C. van der Pol, Thijs van Dalen, Annelie J. E. Vulink, Leander van Gerven, Onno R. Guicherit, Eugenie M. H. Linthorst-Niers, Frederiek van den Bos, Judith R. Kroep, Gerrit Jan Liefers, Johanneke E. A. Portielje
Publikováno v:
Breast Cancer Research and Treatment, 193, 567-577. SPRINGER
Breast cancer research and treatment, 193(3), 567-577. Springer New York
Breast cancer research and treatment, 193(3), 567-577. Springer New York
Purpose Side effects are the main reason for discontinuation of adjuvant endocrine therapy in older adults. The aim of this study was to examine geriatric predictors of treatment discontinuation of adjuvant endocrine therapy within the first 2 years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f264eae5daa2fba28aaa1fcc95b32ffb
https://doi.org/10.1007/s10549-022-06583-7
https://doi.org/10.1007/s10549-022-06583-7
Autor:
Hilde Rosing, Stijn L.W. Koolen, Laura Molenaar-Kuijsten, Annelie J E Vulink, Niels de Vries, Ron H.J. Mathijssen, Stefanie L. Groenland, Marloes G J van Dongen, Alwin D. R. Huitema, C. Louwrens Braal, Neeltje Steeghs, Jos H. Beijnen
Publikováno v:
Clinical Pharmacology and Therapeutics, 111(2), 477-484. Wiley-Blackwell
Palbociclib is an oral inhibitor of cyclin-dependent kinases 4 and 6 used in the treatment of locally advanced and metastatic breast cancer, and is extensively metabolized by cytochrome P450 enzyme 3A4 (CYP3A4). A pharmacokinetic/pharmacodynamic rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43c6bd2e721c934241b5a8cddea185eb
https://doi.org/10.1002/cpt.2455
https://doi.org/10.1002/cpt.2455
Autor:
Annelieke A Lemij, Gerrit Jan Liefers, Marloes G M Derks, Esther Bastiaannet, Marta Fiocco, Titia E Lans, Carmen C van der Pol, Annelie J E Vulink, Leander van Gerven, Onno R Guicherit, Eugenie M H Linthorst-Niers, Jos W S Merkus, Thijs van Dalen, Johanneke E A Portielje, Nienke A de Glas
Publikováno v:
The Oncologist.
BackgroundA decline in physical activity and the ability to perform activities of daily living (ADL) and instrumental activities of daily living (IADL) could interfere with independent living and quality of life in older patients, but may be prevente
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ad83dffcfb65edbefa954cd5182aaee
https://doi.org/10.1093/oncolo/oyad027
https://doi.org/10.1093/oncolo/oyad027
Autor:
Rieneke T. Lugtenberg, Stefanie de Groot, Danny Houtsma, Vincent O. Dezentjé, Annelie J. E. Vulink, Maarten J. Fischer, Johanneke E. A. Portielje, Jacobus J. M. van der Hoeven, Hans Gelderblom, Hanno Pijl, Judith R. Kroep
Publikováno v:
Cancers, 15(6). MDPI
Cancers; Volume 15; Issue 6; Pages: 1691
Cancers; Volume 15; Issue 6; Pages: 1691
Simple Summary: Docetaxel has been approved as an anti-cancer agent in 1995. High rates of hypersensitivity reactions (HSR) and fluid retention were observed when this agent was first introduced. The use of high dose systemic corticosteroids around d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b6dde910724a5797de220c309b36eaf
https://hdl.handle.net/1887/3619418
https://hdl.handle.net/1887/3619418
Autor:
Andrew J, Kassianos, Melinda Y, Hardy, Xinsheng, Ju, Dipti, Vijayan, Yitian, Ding, Annelie J E, Vulink, Kylie J, McDonald, Sarah L, Jongbloed, Robert B, Wadley, Christine, Wells, Derek N J, Hart, Kristen J, Radford
Publikováno v:
European journal of immunology. 42(6)
Human blood myeloid DCs can be subdivided into CD1c (BDCA-1)(+) and CD141 (BDCA-3)(+) subsets that display unique gene expression profiles, suggesting specialized functions. CD1c(+) DCs express TLR4 while CD141(+) DCs do not, thus predicting that the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aa4929ad8c1adcda7753bb6432282559
https://pubmed.ncbi.nlm.nih.gov/22678905
https://pubmed.ncbi.nlm.nih.gov/22678905